terrascend acquisition: TerrAscend Corp. has signed an agreement to acquire Aunt Mary’s Dispensary in Flemington, New Jersey, in a deal that would raise the company’s retail count in the state to five locations if regulators approve the transaction. The company announced the agreement and said the purchase will add a dispensary that generates more than $10 million in annualized revenue.
Deal structure and payment: TerrAscend will pay a total of $9 million for Aunt Mary’s. The transaction begins with a $3 million, five-year unsecured convertible promissory note that gives TerrAscend an option to acquire a 35% interest in the business. If TerrAscend exercises that option, it will pay an additional $6 million in cash. The agreement remains subject to customary closing conditions, including regulatory approval from New Jersey authorities.
Revenue and cash-flow impact: TerrAscend reports that Aunt Mary’s currently produces over $10 million in annualized revenue and expects the store to contribute immediately to company EBITDA (earnings before interest, taxes, depreciation and amortization) and free cash flow once the deal closes. TerrAscend has identified opportunities to raise margins by vertically integrating Aunt Mary’s supply chain and introducing the company’s existing retail brands into the store assortment.
Store profile and timing: Aunt Mary’s opened in February 2023 and operates in a high-traffic retail corridor in Flemington. The dispensary includes roughly 5,200 square feet of retail space. That footprint, combined with the reported revenue level, positions the location as one of the larger single-store sellers in the region.
Brand rollout and market plan: TerrAscend plans to carry its premium brand portfolio at Aunt Mary’s, naming Kind Tree, Legend, Valhalla and Cookies among the labels it intends to stock. The company says introducing its branded products and integrating inventory and cultivation channels will be central to its plan to raise per-unit margin and increase gross profit at the location.
Regulatory compliance and ownership rules: TerrAscend said the structure of the transaction complies with New Jersey’s regulatory framework, which includes provisions for investments in diversely owned cannabis businesses. The initial $3 million promissory note provides a time-limited option structure that aligns with state rules governing ownership changes and minority-investor protections.
Company position and comments: Jason Wild, TerrAscend’s executive chairman, described Aunt Mary’s as a strong performer and said the acquisition fits the company’s strategy of pursuing disciplined, accretive retail opportunities. He emphasized the near-term cash-flow contribution and the potential to widen margins through product and supply integration.
Market context: New Jersey is among the faster-growing state cannabis markets in the U.S., with expanding retail access and increasing consumer demand since adult-use sales began. If approved, this purchase would be TerrAscend’s fifth dispensary in New Jersey, expanding the company’s physical presence in a state with rising per-store sales volumes.
Next steps and timing: The companies did not provide a specific closing date. The transaction must clear customary conditions and receive regulatory approval before transferring ownership or moving forward with the $6 million cash payment tied to the 35% option. TerrAscend said it continues to evaluate additional opportunities to grow its New Jersey retail footprint.
Implications for investors and operators: For investors, the deal highlights a pay structure that combines near-term consideration (the $3 million note) with a contingent cash payment ($6 million) tied to exercise of an ownership option. For operators, the agreement shows a strategy of acquiring established, revenue-producing stores and applying existing brand, supply and retail practices to increase store-level profitability.
Summary: TerrAscend’s agreement to purchase Aunt Mary’s Dispensary is a $9 million transaction structured as a $3 million convertible promissory note plus a $6 million cash option. The dispensary reports more than $10 million in annualized revenue, occupies 5,200 square feet, and would become TerrAscend’s fifth New Jersey store if regulators approve the deal.
